Evidence map›Paper›PMID 42386988›Full record

ArticleZeitschrift fur Gerontologie und Geriatrie2026

Effect of anticholinergic burden on cardiac functions in older patients.

Hakan Fotbolcu, Pınar Soysal

Abstract read
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Gerontologie und Geriatrie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hakan FotbolcuDepartment of Cardiology, Bezmialem Vakif University, Başıbüyük Mahallesi, Emek Caddesi, Narcity, No: 281 A2b Blok D: 56, Maltepe, Istanbul, Turkey. hakan_fotbolcu@yahoo.com.
Pınar SoysalDepartment of Geriatric Medicine, Bezmialem Vakif University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study investigated the detrimental effects of a high anticholinergic burden on both myocardial systolic-diastolic functions and electrical functions in older adults.

methodsA total of 24 patients with a high anticholinergic burden and 26 control patients were enrolled. The anticholinergic burden was assessed using the anticholinergic burden (ACB) scale. An ACB of ≥ 2 was categorized as high anticholinergic burden, while those with an ACB score of 0 were included in the control group. Each participant's diastolic and systolic functions were evaluated using transthoracic two-dimensional, conventional and tissue Doppler echocardiography. Heart rate and corrected QT interval (cQT) were also measured to assess electrophysiological changes.

resultsThe mean age was 72.5 ± 6.6 years. Biventricular systolic and diastolic functions were impaired in the high ACB patients. Systolic function parameters such as lateral‑S (8.04 ± 1.43 vs. 9.54 ± 1.82, p = 0.003), septal‑S (7.33 ± 0.64 vs. 8.27 ± 1.31, p = 0.007) and tricuspid‑S (12.42 ± 1.72 vs. 14.31 ± 3.17, p = 0.025) values were lower in the ACB patients compared to the control group. The indicator of left ventricular (LV) filling pressure (E/E') was higher in ACB patients than in the controls (11.61 ± 2.89 vs. 8.83 ± 1.68, p < 0.001). There was no significant difference in terms of heart rate and cQT. Serum albumin levels were lower in ACB patients comparing to controls (4.08 ± 0.33 vs. 4.38 ± 0.27, p = 0.001).

conclusionA high anticholinergic burden is associated with moderately impaired systolic and diastolic functions, yet on its own, it does not sufficiently explain the increased hospitalization and mortality observed in older adults.

Indexed as

Anti-cholinergic burdenCatabolismDiastolic functionsHeart rateSystolic functions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.